Stephen Van Deventer
Chairman, Chief Executive Officer & Chief Financial Officer
Mr. Van Deventer is an experienced business person and corporate director. Specialising in international corporate relations and business development over the last thirty years, Mr. Van Deventer has focused on launching small to medium-sized companies into the public markets in Canada, the United States and Europe. He has also owned and operated private businesses.
Mak JawadekarPh.D.
President & Chief Science Officer
Dr. Mak Jawadekar worked at Pfizer Inc. in Groton-New London, Connecticut, for 28 consecutive years. His most recent position was as a Director of Portfolio Management at Pfizer Inc. He was responsible for Drug Delivery Technology Assessment function involving external ‘Drug Delivery’ technologies. He has extensive experience in creating and cultivating external partnerships and alliances for drug delivery technologies. He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics at the University of Minnesota.
Harry ParekhPh.D., MRPharmS
Chief Research Officer
Based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), Dr. Parekh also holds adjunct positions at the National University of Singapore, and Manipal University, India. Dr. Parekh heads the Drug/Gene Delivery Group at PACE-UQ with his team developing highly innovative and translational medicine delivery systems in-conjunction with physicians whose expertise span cancer, obesity-&-diabetes, macular disease, infectious disease and traditional (Chinese) medicine.
Andrea Ortega
Executive Assitant & Office Manager
Ms. Ortega is a professional currently studying commerce while gaining valuable experience in the hospitality and marketing industries over the past two years. Ms. Ortega excels at streamlining operations and optimizing marketing strategies, all while serving as an accomplished executive assistant.